Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Luderer

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The American Journal of Medicine|September 1, 1981
Acute renal failure, hemolytic anemia and skin rash associated with captopril therapyJ R Luderer, A C Schoolwerth, R A Sinicrope, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1994
Acute effects of increasing doses of nicorandil on renal function in manD L Wolf, G L Jungbluth, C M Metzler, et al.
Journal of Clinical Pharmacology|November 1, 1987
The effect of itazigrel and aspirin on the mucosa of the esophagus, stomach, and duodenum of normal subjectsD M Demke, J R Luderer, L K Wakefield, et al.
Prostaglandins, Leukotrienes, and Medicine|May 1, 1983
The release of thromboxane A2 and prostacyclin following experimental acute pulmonary embolismW C Reeves, L M Demers, M A Wood, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The pharmacokinetics and haemodynamic effects of continuous nicorandil infusion in healthy volunteersD L Wolf, A E Hearron, C M Metzler, et al.
International Journal of Cardiology|May 1, 1994
Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest painJ M Arnold, P R Kowey, D L Wolf, et al.
Cancer|April 1, 1977
Plasma prostaglandins in hypercalcemic patients with neoplastic diseaseL M Demers, J C Allegra, H A Harvey, et al.
The American Journal of Medicine|March 1, 1986
Familial essential thrombocythemiaM E Eyster, S L Saletan, E M Rabellino, et al.
Clinical Pharmacology and Therapeutics|July 1, 1984
Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenonJ R Luderer, G G Nicholas, M M Neumyer, et al.
Cancer|June 1, 1977
Immunosuppression and human cancer: role of prostaglandinsH A Harvey, J C Allegra, L M Demers, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The American Journal of Medicine|September 1, 1981
Acute renal failure, hemolytic anemia and skin rash associated with captopril therapyJ R Luderer, A C Schoolwerth, R A Sinicrope, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1994
Acute effects of increasing doses of nicorandil on renal function in manD L Wolf, G L Jungbluth, C M Metzler, et al.
Journal of Clinical Pharmacology|November 1, 1987
The effect of itazigrel and aspirin on the mucosa of the esophagus, stomach, and duodenum of normal subjectsD M Demke, J R Luderer, L K Wakefield, et al.
Prostaglandins, Leukotrienes, and Medicine|May 1, 1983
The release of thromboxane A2 and prostacyclin following experimental acute pulmonary embolismW C Reeves, L M Demers, M A Wood, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The pharmacokinetics and haemodynamic effects of continuous nicorandil infusion in healthy volunteersD L Wolf, A E Hearron, C M Metzler, et al.
International Journal of Cardiology|May 1, 1994
Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest painJ M Arnold, P R Kowey, D L Wolf, et al.
Cancer|April 1, 1977
Plasma prostaglandins in hypercalcemic patients with neoplastic diseaseL M Demers, J C Allegra, H A Harvey, et al.
The American Journal of Medicine|March 1, 1986
Familial essential thrombocythemiaM E Eyster, S L Saletan, E M Rabellino, et al.
Clinical Pharmacology and Therapeutics|July 1, 1984
Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenonJ R Luderer, G G Nicholas, M M Neumyer, et al.
Cancer|June 1, 1977
Immunosuppression and human cancer: role of prostaglandinsH A Harvey, J C Allegra, L M Demers, et al.
Pageof 3